News - May 4, 2020

2nd EUCOPE/DIA Workshop on ATMPs in the EU

On 27 and 28 May, EUCOPE and Drug Information Association (DIA) jointly organise an online workshop on ATMPs and Innovative Gene and Cell Therapies.

The event is a unique opportunity to hear directly from the Industry and Regulatory representatives about the challenges, opportunities and political implications of advanced therapies. This workshop will include a wide range of topics that will help you and your team make more informed decisions on regulatory strategies and evidence packages – as well as market access challenges – which are key topics for cell and gene therapy developers.

What will be discussed?

  • Development of ATMPs – challenges and opportunities from industry and Authority perspective
  • ATMP combined products
  • Examples, Case Studies and specific challenges for SMEs
  • Emerging techniques on gene editing
  • Registries supporting Real World Evidence (RWE)
  • Market access and pricing & reimbursement of ATMPs in the EU – challenges and political implications
  • The Pricing and Reimbursement perspective
  • Pricing & HTA challenges for ATMPs – Case study on CAR-T cells

Speakers will include Alexander Natz, EUCOPE Secretary General and other experts representatives of pharmaceutical companies and regulatory authorities.

For more information and register, please see here.